article thumbnail

Medicare Part D Claims Have Increased, But 340B Prescriptions Increased Faster

Pharmacy Times

in 2013 to 19.3% The proportion of prescriptions by a 340B-affiliated physician increased from 9.4% in 2020, but the prescriptions filled by 340B pharmacies increased from 18.4% to 49.9%.

article thumbnail

Study finds hepatitis C cure saved Medicaid $15 billion

PhRMA

The study finds that since curative direct-acting antiviral medications for hepatitis C were approved in 2013, even after factoring in the cost of treatment, Medicaid has saved an estimated $15 billion in avoided health care costs and nearly 285,000 Medicaid enrollees are estimated to have been cured.

211
211
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Viagra May Alleviate Dysmenorrhea-Related Pain, However Funding Challenges Have Limited Clinical Research

Pharmacy Times

The early phase clinical trial, which ended prematurely in 2013 due to funding challenges, further illustrates disparities in health equity in clinical research.

50
article thumbnail

Pumping breastmilk in bathrooms is a common, albeit unspoken, practice at health care conferences

STAT

This was back in 2013, when such accommodations were a rarity. Even though Erin Booth was not thrilled about having to travel to Philadelphia for a conference at six weeks postpartum, this one at least advertised having a private lactation space.

145
145
article thumbnail

Q&A: The scientific integrity sleuth taking on the widespread problem of research misconduct

STAT

Bik first became interested in plagiarism as a hobby while working as a researcher at Stanford University in 2013. She later began specializing in image duplication specifically, which she believes is a more serious problem for science as a whole. Read the rest…

143
143
article thumbnail

STAT+: Payments by drug and device makers to doctors remain widespread, but also vary considerably

STAT

From 2013 to 2022, pharmaceutical and device companies made more than 85 million payments totaling $12.1 The financial ties between drug and device makers and some physicians remains pervasive, despite concerns such relationships may influence medical practice, according to a new analysis of payments made over a recent 10-year span.

93
article thumbnail

STAT+: AbbVie CEO Gonzalez to step down after a decade fiercely defending its top seller, Humira

STAT

AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July.

139
139